News
Tempero Bio, Inc., a clinical-stage biopharmaceutical company developing transformative treatments for substance use disorders, today announced the closing of a $70 million Series B financing. The ...
Windows 11 Despite the fact that the TMP 2.0 and secure boot requirements have been known for a while now, many users are still confused as to why Windows 11 is requiring what has been, to date ...
Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) announces that its partner Tempero Bio, Inc. has initiated a Phase 2 trial of TMP-301, a potent, selective and orally available mGluR5 ...
After Meghalaya Chief Minister Conrad K. Sangma, Tipra Motha Party (TMP) supremo Pradyot Bikram Manikya Debbarma, on Saturday ...
Tipra Motha Party (TMP) supremo Pradyot Bikram Manikya Debbarma said on Friday that Union Home Minister Amit Shah ha ...
2.TMP.EXE Information This is an undesirable program. This file has been identified as a program that is undesirable to have running on your computer.
A Phase 2 trial evaluating TMP-301's efficacy and safety in patients with alcohol use disorder. A drug-drug interaction (DDI) study assessing TMP-301 in individuals using cocaine.
Tokyo, Japan and Cambridge, UK, 25 March 2025 - Nxera Pharma Co., Ltd. ("Nxera” or "the Company”; TSE 4565) announces that its partner Tempero Bio, Inc. has initiated a Phase 2 trial of TMP-301, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results